A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Titel:
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Auteur:
Cheung, Matthew C. Mittmann, Nicole Owen, Carolyn Abdel-Samad, Nizar Fraser, Graeme A.M. Lam, Selay Crump, Michael Sperlich, Catherine van der Jagt, Richard Prica, Anca Couban, Stephen Woyach, Jennifer A. Ruppert, Amy S. Booth, Allison M. Mandrekar, Sumithra J. McDonald, Gail Shepherd, Lois E. Yen, Hope Chen, Bingshu E. Hay, Annette E.